Nashville-based boutique investment banking and wealth management firm Avondale Partners recently announced the addition of two senior research analysts focused on healthcare and the life sciences.

Sung Ji Nam joined the firm as senior vice president and senior research analyst with a focus on life science tools and diagnostics. Working from the firm’s New York office, Nam was previously in a similar role at Cantor Fitzgerald and Gleacher and Company. She began her equity research career at JP Morgan. Other prior experience includes being a senior program officer of Science, Higher Education ad Healthcare at the Gordon and Betty Moore Foundation and in healthcare investment banking at Robertson Stephens. Nam earned an undergraduate degree in chemistry and an MBA from Harvard University.

Greg Bolan comes to Avondale as a senior research analyst focused on healthcare technology and pharmaceutical services. Previously, he served as managing director of Healthcare Equity Research with Sterne Agee’s Nashville office. He earned his degree in Finance from Emory University’s Goizueta Business School.